Impact of different visceral metastatic sites on survival in metastatic prostate cancer patients.

ABSTRACT:

Introduction

Visceral metastasis is an important predictor for poor outcomes in prostate cancer, however, the prognostic significance surrounding the specific sites of visceral metastasis remains unclear. The aim of this study was to evaluate the impact of different visceral metastatic sites on survival in patients with prostate cancer.

Methods

We identified patients with metastatic prostate cancer between January 1, 2010 and December 31, 2023 using the TriNetX database. Patients were divided into 4 cohorts according to their specific metastatic sites: lung metastases, brain metastases, liver metastases, and bone metastases. Survival analysis was calculated using the Kaplan-Meier method and Cox regression models.

Results

In total, 59,875 patients diagnosed with metast

SUBMITTER: Lai GS 

PROVIDER: S-EPMC11379235 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature